Literature DB >> 19559610

Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer.

Hiroyuki Takei1, Masafumi Kurosumi, Takashi Yoshida, Jun Ninomiya, Yuko Ishikawa, Yuji Hayashi, Katsunori Tozuka, Hideki Asakawa, Hanako Oba, Kenichi Inoue, Toshio Tabei.   

Abstract

It remains to be clarified whether a positive sentinel lymph node biopsy (SLNB) can predict the number of metastatic axillary nodes. This study examined a consecutive series of women with unilateral invasive breast cancer who underwent axillary lymph node dissection after an intra-operative positive SLNB. The numbers of positive and negative sentinel lymph nodes (SLNs) were analyzed for a likelihood of pN1a, pN2a, and pN3a diseases as per the UICC TNM classification. Of the 368 study patients, 165 (45%) had one positive SLN and one or more negative SLNs. This result represented the most common combination of positive and negative SLNs. It was also the most predictive indicator (93%) of pN1a disease and the least predictive indicator (7% or 0%) of pN2a or pN3a disease, respectively. The numbers of positive and negative SLNs can predict the number of metastatic axillary nodes in breast cancer patients.

Entities:  

Mesh:

Year:  2009        PMID: 19559610     DOI: 10.1016/j.breast.2009.05.007

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  1 in total

1.  Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.

Authors:  Hiroyuki Takei; Takashi Yoshida; Masafumi Kurosumi; Kenichi Inoue; Hiroshi Matsumoto; Yuji Hayashi; Toru Higuchi; Sayaka Uchida; Jun Ninomiya; Kazuyuki Kubo; Hanako Oba; Shigenori Nagai; Toshio Tabei
Journal:  Int J Clin Oncol       Date:  2012-05-16       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.